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Adult hematopoiesis takes place in the perivascular zone of the bone cavity, where
endothelial cells, mesenchymal stromal/stem cells and their derivatives such as
osteoblasts are key components of bone marrow (BM) niches. Defining the contribution
of BM adipocytes to the hematopoietic stem cell niche remains controversial. While
an excess of medullar adiposity is generally considered deleterious for hematopoiesis,
an active role for adipocytes in shaping the niche has also been proposed. We thus
investigated the consequences of total adipocyte deletion, including in the BM niche,
on adult hematopoiesis using mice carrying a constitutive deletion of the gene coding
for the nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ). We show
that Pparg1/1 lipodystrophic mice exhibit severe extramedullary hematopoiesis (EMH),
which we found to be non-cell autonomous, as it is reproduced when wild-type donor
BM cells are transferred into Pparg1/1 recipients. This phenotype is not due to a specific
alteration linked to Pparg deletion, such as chronic inflammation, since it is also found in
AZIPtg/+ mice, another lipodystrophic mouse model with normal PPARγ expression, that
display only very moderate levels of inflammation. In both models, the lack of adipocytes
alters subpopulations of both myeloid and lymphoid cells. The CXCL12/CXCR4 axis
in the BM is also dysregulated in an adipocyte deprived environment supporting the
hypothesis that adipocytes are required for normal hematopoietic stem cell mobilization
or retention. Altogether, these data suggest an important role for adipocytes, and possibly
for the molecular interactions they provide within the BM, in maintaining the appropriate
microenvironment for hematopoietic homeostasis.
Keywords: lipodystrophy, PPARγ null mice, AZIPtg/+ mice, bone marrow adipocytes, hematopoiesis,
extramedullary hematopoiesis, inflammation, non-cell autonomous alteration of hematopoiesis in PPARγ null
mice
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INTRODUCTION
Bones and hematopoiesis are intimately linked. Adult
hematopoiesis takes place in the bone cavity, where a
variety of cells and molecular contacts create a niche allowing
hematopoietic stem cells (HSCs) to undergo cell division and
differentiation in a highly regulated manner. The concept of a
stem cell niche was first coined by Schofield, who hypothesized
that the cellular environment in the bone compartment
creates multiple cell-cell contacts that are crucial for HSC
function (1). Depending on the location in the bone cavity, the
different cell types involved and different functions proposed,
BM niches are described as endosteal, reticular, sinusoidal
or perivascular, mainly involving osteoclast precursors,
osteoblast and spindle-shaped osteoblast precursors (SNO),
CXCL12-abundant-reticular (CAR) cells, Nestin+mesenchymal
stromal cells (MSCs), E-selectin+ endothelial cells, LeptinR+
perivascular stromal cells, and non-myelinating Schwann cells,
respectively [reviewed in (2–4)].
The role of adipocytes, present in large numbers in the
BM cavity, remains disputed. Adipocytes, which are the
specialized cells of adipose tissue, store energy in the form
of lipids, and release it when required by the organism.
Adipocytes also secrete cytokines known as adipokines that
participate in endocrine-mediated homeostasis (5). Both gain
of adipose tissue, as in obesity, and the generalized lack of
adipose tissue (generalized lipodystrophy), such as is seen in
Berardinelli-Seip syndrome, causes metabolic disorders such
as hypertriglyceridemia, metabolic syndrome, and type 2
diabetes (6, 7). While most adipocytes are found within depots
forming the diverse adipose tissues, some of them are also
found in substantial numbers in a less organized manner,
particularly within the BM where their (local) role is less well
characterized (8). The first link between adipocytes and the
bone microenvironment is the fact that both adipocytes and
osteoblasts are derived from a commonmesenchymal progenitor,
and their respective production is due to a balance between
adipogenesis and osteoblastogenesis. A more direct contribution
of adipocytes to the stem cell niche in the BM has been
previously explored, albeit with contradictory results. First, using
leptin deficient mice (ob/ob mice), Claycombe et al. showed
that supplementation with leptin, a major adipokine secreted
by adipocytes, rescued appropriate levels of lymphopoiesis and
myelopoiesis in the BM (9). Second, a combination of in
vitro and in vivo experiments has suggested that adiponectin,
another adipokine expressed by adipocytes in the BM, is
required for optimal HSC growth (10, 11). Third, BM adipocytes
also secrete Stem Cell Factor, which contributes to restoring
hematopoiesis after irradiation in the long bones but not in the
vertebral bones (12). Finally, experiments performed in AZIP-F1
(AZIPtg/+) transgenic mice carrying a C/EBP dominant negative
transgene that induces deletion of mature adipocytes, showed
improved marrow engraftment after irradiation, suggesting that
in this specific context adipocytes are negative regulators of
hematopoiesis (10, 13). A similar negative effect is also proposed
when adipocytes overfill the medullary space upon BM failure in
Fanconi Anemia (14).
In the present report, we reveal a novel aspect of the cross-
talk between hematopoiesis and adipocytes, by exploiting
a generalized lipodystrophic mouse model carrying a
constitutive total-body deletion of the nuclear receptor
peroxisome proliferator-activated receptor-γ (PPARγ)
(15, 16). Pparg1/1 mice show a complex phenotype
including total lipoatrophy, increased lean mass, and
hypermetabolism. They develop severe type 2 diabetes,
characterized by hyperglycemia, hyperinsulinemia, polyuria,
and polydipsia (personal communication, manuscript in
preparation). Herein, we demonstrate that the total lack of
adipocytes is accompanied by extramedullary hematopoiesis
(EMH), which is defined as the production of blood cells
occurring outside of the BM, mainly in the liver and spleen
(17). We further evaluate the causes of this EMH and
provide new insights in the role of adipocyte signaling in
hematopoiesis.
MATERIALS AND METHODS
Mice
Genotype designations in this work follow the rules
recommended by the Mouse Genome Database Nomenclature
Committee. Procedures using mice were authorized by the
Cantonal Commission for Animal Experimentation of the
Canton of Vaud and carried out in accordance with the
International Guiding Principles for Biomedical Research
Involving Animals. Sox2-Cre transgenic mice (Sox2-Cre tg/+;
Tg(Sox2-cre)1Amc/J), CD45.1+ (B6.SJL-PtprcaPepcb/BoyJ)
mice (Jackson Laboratory, Bar Harbour, MA), and ob/ob mice
were kept in the University of Lausanne Animal Facility.
Construction of the Pparg floxed (hereafter referred to as
Ppargfl) and Pparg-null alleles resulting from Cre recombination
(hereafter referred to as Pparg1), as well as the mating strategy
for the generation of Sox2-Cretg/+Ppargem1/1 (Pparg1/1)
mice and their control littermates (CTL) with no Sox2-Cre
transgene but two functional Pparg alleles (Ppargfl/+) have
been previously described (16, 18). This strategy ended
up with a conditional epiblast-specific deletion of Pparg
mediated by the Sox2-Cre transgene. The preservation of
Pparg expression in the trophoblast (16) circumvented the
embryonic-lethality of homozygous PPARγ knockout mice due
to a placental defect (15, 16). Normal placental development
allows Sox2-Cretg/+Ppargem1/1 pups to be born, and as
expected, these mice are totally deprived of any form of
adipose tissue. Both male and female mice 12–22 weeks
of age were used. AZIP/F1 mice on an FVB background
[Tg(AZIP/F)1Vsn; hereafter referred to as AZIPtg/+] and
corresponding wild-type FVB controls were obtained from
Charles Vinson and the colony was raised as previously
described (19).
No Pparg expression could be detected in the long bones
of Pparg1/1 mice and the total lack of adipocytes in the
BM in these two models, was confirmed by using Resistin,
an adipokine specifically expressed by adipocytes and, herein,
used as a surrogate marker for the presence of mature
adipocytes. Expression of Resistin was indeed barely measurable
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above the detection threshold in mRNA extracted from
Pparg1/1 bones, and at very low levels in AZIPtg/+ bones
(Supplementary Figure S1).
Flow Cytometry
BM cell suspensions from all mouse strains described above
were prepared by crushing the long bones (2 femurs and
2 tibias per mouse) into DMEM/3% FCS. Bone fragments
were removed by filtration through 40-µm filters. Splenocyte
suspensions were obtained by mashing the organs through sieves
into DMEM/3% FCS, washing by centrifugation and filtering
through a 40-µm filter cap. Liver hematopoietic mononuclear
cells were obtained by mashing entire livers through sieves,
after which the cells were washed in DMEM/3% FCS and
centrifuged using a Percoll (GE Healthcare) gradient (40%
Percoll layered over 80% Percoll) for 30 mins at 2,000 rpm to
remove hepatocytes and other non-hematopoietic cells. Cells
localized at the interface were recovered, diluted in DMEM/3%
FCS, centrifuged and filtered through 40-µm filter caps. Single-
cell suspensions were stained as previously described (20).
Monoclonal antibody conjugates used for flow cytometry are
listed in Supplementary Table S1. Cells were analyzed on a 5-
laser LSR II cytometer equipped with 355, 405, 488, 561, and
640-nm lasers (Becton Dickinson, San Jose, CA), and the data
were analyzed with FlowJo V9 software (TreeStar, Ashland,
OR).
Colony Forming Cell (CFC) Assay
Splenocyte cell suspensions were obtained by mashing the spleen
through sieves into DMEM/3% FCS, washing by centrifugation
then filtering through 70-µm filter caps. BM cells suspensions
were obtained as described above. Splenocytes (3 × 105) and
BM cells (2 × 104) were seeded into 35mm dishes in Mouse
Methylcellulose Complete Media containing cytokines/growth
factors such as EPO, IL-3, IL-6, SCF, or the combination thereof
according to the manufacturer’s instructions (R&D Systems).
After 10–12 days of culture at 37◦C in 5% CO2, Colonies were
identified by eye with phase-contrast microscopy.
BM Transplantation
BM chimeras were prepared as previously described (21). Briefly,
12-week old host mice (CD45.1+) were lethally irradiated (1000
rads) and reconstituted with 107 T-depleted BM cells (CD45.2+)
from either Pparg1/1 mice or their littermate controls (CTL).
For reverse chimeras, 12-week old host mice (Pparg1/1 or
CTL) were reconstituted with 107 T-depleted BM cells from
CD45.1+ wild-type controls. Hematopoietic reconstitution was
assessed by FACS staining of ficoll-purified peripheral blood
cells 6 weeks after transfer as described above. Mice were
euthanized and analyzed 12 weeks after transfer. Owing to
variable reconstitution efficiency between animals, the BM
chimera results were expressed as the percentage of donor-
derived cells.
Quantitative RT-PCR
Total RNA was isolated from long bones (bone fragments and
BM combined), liver, and spleen, using TRIzol LS reagent
(ThermoFisher, Waltham, MA) and purified with the RNeasy
kit (Qiagen, Hilden, Germany). RNA quality was verified by
chip electrophoresis (Agilent 2100 Bioanalyzer; Santa Clara,
CA), and the concentration was determined using Nanodrop
(Wilmington, DE). Total RNA (500 ng to 1 µg) was reverse-
transcribed using the iScript
TM
cDNA Synthesis Kit (Bio-Rad
Laboratories, Hercules, CA) according to the manufacturer’s
instructions. Real-time PCR was performed with SYBR R©
Green PCR mastermix using an ABI PRISM R© 7900 PCR
machine (ThermoFisher). The results were normalized to
the levels of Actin beta (Actb). For primer sequences, see
Supplementary Table S2.
Histology
Spleen were fixed in 4% paraformaldehyde and paraffin
embedded. Four micro meter paraffin sections were stained
with hematoxylin and spleen area as well as white pulp (WP)
area were calculated by measuring spleen or WP surface area,
using ImageJ software (http://rsbweb.nih.gov/ij/). Red pulp (RP)
area was calculated as total spleen area minus WP areas. One
representative section per spleen and 3 spleens were analyzed per
genotype.
Immunohistochemistry was performed on 8 µm-thick frozen
sections of OCT-embedded spleen, which were fixed using
acetone followed by primary and secondary antibodies or
streptavidin (found in Supplementary Table 1), as described
previously (22). Images were acquired with a Zeiss Axioplan
microscope and treated with Photoshop (Adobe) or Image J
opensource software.
Serum Levels of Parathyroid Hormone
(PTH) and Inflammatory Markers
Blood was obtained by cardiac puncture immediately after
euthanasia. After clotting and centrifugation, serum was
collected and stored at −80◦C until use. Parathyroid
hormone (PTH) was measured by ELISA according to the
manufacturer’s protocol (Stoughton, MA; LifeSpan Biosciences,
Inc., Seattle,WA). Serum levels of Serum Amyloid A (SAA),
IL-1β and IL-6 were measured using commercial ELISA kits
(Bio-techne, Abingdon, UK). Assays were run in duplicate
using adequate dilution buffer (for SAA, sera were diluted
between 1:200 and 1:2,000; for IL-1β and IL-6, sera were
used pure or diluted 1:2), according to the manufacturer’s
protocol. A four-parameter logistic formula was used to calculate
the sample concentrations from the standard curves. Limit
of quantification was 0.022 ng/ml for SAA (manufacturer’s
data).
Statistical Analyses
The statistical analysis was performed using GraphPad Prism
6 software. Two-group comparisons were performed using
Student’s t-tests or Mann-Withney U-test for non-parametric
data, as indicated. All data are presented as mean± SEM.
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RESULTS
Significant Increase in Hematopoietic Cells
in the Spleen and Liver of Lipodystrophic
Pparg1/1 Mice
To explore both the systemic and local involvement of adipose
tissue, we characterized the hematopoietic phenotype of mice
carrying a constitutive deletion of the two Pparg alleles. We
have previously shown that the ablation of PPARγ expression
leads to the total absence of both white and brown adipose
tissue (18) and the development of various metabolic disorders,
which include the early onset of a type 2 diabetes [(23)
and unpublished observations]. Adult Pparg1/1 mice had
significantly enlarged spleens and livers, both in volume
and weight (Figures 1A,B). Histological analyses revealed an
alteration of the red pulp of the spleen, with an increase in the
red pulp compartment size (Supplementary Figures S2A,B)
and the presence of numerous and large polynuclear cells
corresponding to megakaryocytes (Figure 1C). The total surface
occupied by the white pulp was similar in the spleen sections
from control and Pparg1/1 mice while the average white pulp
cords were smaller (Supplementary Figures S2A,B). However,
the overall perturbation might lead to an underestimation
of the white pulp. Immunohistochemical characterization
of the spleen further showed that the segregation of various
immune cells into the red and white pulp compartment as
well as into the B and T zone of the white pulp was not
significantly altered in spleens of Pparg1/1 mice. Similarly,
only a mild reduction in splenic germinal centers was
observed (Supplementary Figures S2C–E). During fetal life
the liver and spleen are the major sites of hematopoiesis,
and the perturbations observed, particularly the presence
of numerous megakaryocytes, are suggestive of altered
hematopoiesis.
Consistent with a perturbation of hematopoiesis, significant
increases in total hematopoietic mononuclear cell numbers were
observed in the liver and spleen of Pparg1/1 mice (Figure 1D).
Flow cytometric analysis of the major hematopoietic subsets
in these organs showed significant increases (10-fold or
more) in the numbers of granulocytes, macrophages
and erythroblasts.
In contrast to these peripheral organs, the total numbers
of hematopoietic cells in the BM of Pparg1/1 mice were
marginally decreased compared to the controls (Figure 1D).
While the numbers of granulocytes and macrophages in the
BM did not differ in Pparg1/1 mice compared to the controls,
lymphopoiesis was affected with numbers of B cells and T cells
reduced 1.5-fold in Pparg1/1 mice, and erythroblasts decreased
∼two-fold (Figures 1E,F). However, this hematopoietic cell
dysregulation was associated with only minor changes in the
peripheral blood counts (Supplementary Figure S3). Thus, while
BM hematopoiesis is mildly altered in the absence of PPARγ,
substantial increases in numbers of myeloid (granulocytes and
macrophages) and erythroid (erythroblasts and RBCs) lineage
cells are observed in peripheral hematopoietic organs such as the
liver and spleen.
Lipodystrophic Pparg1/1 Mice Exhibit
Active Extra-Medullary Hematopoiesis
To determine whether the massive increase in hematopoietic
cells observed in the peripheral organs was due to a local
increase in their production, we assessed the number of
HSCs and progenitor cells in these organs as well as in the
BM. Under homeostatic conditions, adult hematopoiesis occurs
almost exclusively in the BM, where mature hematopoietic
lineages are normally produced from HSCs and progenitor cells
(Supplementary Figure S4) located in specialized BM niches
(24). However, under certain conditions (such as BM failure,
myelostimulation, or inflammation), substantial numbers of
HSCs and multi-potent progenitor cells (MPPs), as well as
developing myeloid and erythroid lineages, can be found in
peripheral organs such as the spleen and liver, contributing to an
extramedullary hematopoiesis (EMH) [reviewed in (17)].
To evaluate and identify cells belonging to the different
hematopoietic precursor populations, we analyzed by flow
cytometry the LSK (Lin−, Sca-1+, cKit-r+) and LK (Lin−,
Sca-1−, cKit-r+) populations. The LSK subset contains long-
term (LT-) and short-term (ST-) HSCs, and several Multi-
Potent Progenitors (MPPs) populations, while the LK subset
contains the Common Myeloid Progenitors (CMPs), and gives
rise to both Megakaryocyte Erythroid Progenitors (MEPs)
and Granulocyte Monocyte Progenitors (GMPs; see also
Supplementary Figure S4). Significant increases in both the
relative proportion and total numbers of LSK and LK cells were
observed in the spleen and liver of Pparg1/1 mice compared to
control mice. In contrast, the absolute and relative number of
LSK and LK cells in the BM of Pparg1/1 mice were modestly
affected (Figures 2A–C).
To further identify subsets present in the LSK population,
we analyzed the distribution of the markers CD34, CD48, and
CD150, which define LT- and ST-HSCs as previously described
[(20); Supplementary Figure S4]. Although LT-HSC (CD34−
CD48− CD150+) andMPP1 (ST-HSC; CD34+ CD48+ CD150+)
subsets were marginally decreased in the BM, the MPP2 (CD34+
CD48− CD150+) and MPP3/MPP4 (CD34+ CD48+ CD150−
CD135+/−) subsets were unchanged (Figure 2C). Thus, the HSC
and MPP subsets were largely unaffected in the BM of mice
lacking PPARγ. In contrast, a global 10- to 100-fold increase
in LT-HSC and all MPP subsets (MPP1-4) was observed in the
spleen and liver of Pparg1/1 mice with no changes in their
relative proportions compared to those seen in the BM of wild-
type controls. These important increases were still observed when
calculated as a % of the total cell number in these two organs
(Figures 2D,E). The clonogenic potential of these hematopoietic
precursor populations found in the spleen was also confirmed by
performing a Colony Forming Unit assay on BM and spleen cells
(Supplementary Table S3).
As B cells and T cells are derived from hematopoietic
progenitors via a Common Lymphoid Precursor (CLP), which
is defined as Lin−, Sca-1lo, cKit-rlo and CD27+, CD127+,
CD135+(25), we quantified the proportion and number of CLPs
in the BM and spleen of control and Pparg1/1 mice. No
significant changes were observed in the proportion or in the
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FIGURE 1 | Evaluation of hematopoiesis-derived cell populations in the bone marrow (BM) and peripheral organs of Pparg1/1 mice. (A) Representative photographs
of the spleens and livers of Pparg1/1 (γ1/1) mice (lower panels) and littermate control (CTL) mice (upper panels). (B) Spleen and liver weight in grams (top panels)
and expressed as % of the body weight (bottom panels). (C) Hematoxylin & eosin staining of spleen sections; White pulp areas are circled by a dotted line. The white
arrow indicates one of the numerous megakaryocytes present in the red pulp in Pparg1/1 mice. The black bar indicates 200 micrometers. (D) Total hematopoietic cell
(Continued)
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FIGURE 1 | numbers in the BM (2 tibias and 2 femurs from each mouse), spleen, and liver of control and Pparg1/1 mice. Mean ± SEM, n = 7–8 mice per genotype.
(E) Total numbers of mature hematopoietic cell subsets in the BM (left panel), spleen (middle panel) and liver (right panel) of control (dark bars) and Pparg1/1 (light
bars) mice. (F) Same as in (E), with cell numbers expressed as a % of the total cell number in the corresponding organ. T cells (CD3+); B cells (B220+); Gran:
granulocytes (Gr1+CD11b+), Macs: macrophages (Gr1−CD11b+), Ebs: erythroblasts (Ter119+CD71+); Mean ± SEM n = 7–8 mice per genotype. All significant
p-values are indicated above the corresponding bars.
number of CLPs in the BM and spleen of Pparg1/1 compared
to control mice (data not shown).
Taken together, the increases observed in these HSC and
progenitor cell subsets along with the increase in mature myeloid
and erythroid subsets in peripheral organs are consistent with a
significant EMH occurring in Pparg1/1 mice.
The EMH Observed in Pparg1/1 Mice Is
Non-cell Autonomous
To determine whether the EMH observed in Pparg1/1 mice
was driven by a hematopoietic cell-autonomous mechanism
or by a perturbation of the BM microenvironment, BM
transplantation was performed. Lethally γ-irradiated CD45.1+
wild-type recipient mice were reconstituted with either
Pparg1/1 or control littermate T-depleted BM cells (CD45.2+).
After 3 months, reconstitution from the donor was verified
by staining peripheral blood lymphocytes (PBLs) for the
allelic markers CD45.2 and CD45.1, and the mice were
sacrificed for organ analyses. When wild-type recipients were
reconstituted with donor BM from Pparg1/1 or control
mice, no significant difference was observed in either the
number or proportions of most mature hematopoietic cell
types (Supplementary Figure S5A). Furthermore, there was no
evidence of EMH in these chimeras, as no increases in LSK or LK
cells were observed in the spleen or the liver (Figure 3A).
We then performed the reciprocal experiment in which
lethally irradiated Pparg1/1 (CD45.2+) recipients were
reconstituted with wild-type BM from CD45.1+ mice (reverse
chimeras). In contrast to what we observed when using WT
recipients, the EMH observed in the peripheral organs of
Pparg1/1 recipient mice was largely recapitulated (Figure 3B).
Increased numbers and proportions of erythroblasts,
granulocytes, lymphocytes, and macrophages were observed
in the spleen (Supplementary Figure S5B), and liver (data not
shown) in these reverse chimeras. Further evidence of EMH
was provided by the increase in proportions of LSK and LK
cells in the peripheral organs of Pparg1/1 recipients, but not
of control recipients, reconstituted with wild-type donor BM
(Figure 3B).
Taken together, these results indicate that the EMH observed
in Pparg1/1 mice is non-cell autonomous. Although LT-HSCs
(and other stem/progenitor subsets) appeared to home to and
seed normally in the BM cavity in lethally irradiated Pparg1/1
mice, they were also able to efficiently seed peripheral organs
such as the spleen and liver and to mobilize to these organs.
This suggests that the resulting EMH, rather than a defect of
the hematopoietic cells themselves, was driven either by systemic
cues or by changes in the microenvironment or factors produced
by cells within the local microenvironment.
Respective Contributions of Inflammation
and Lipodystrophy to EMH Onset
One important known systemic cause of EMH is inflammation.
In a previous report, we showed that Pparg1/1 mice have altered
skin hair follicles, which with aging provoke an inflammatory
response in the skin (18). To evaluate the contribution of these
systemic disorders in the occurrence of EMH in Pparg1/1
mice, we analyzed another mouse model that shares a similar
phenotype with respect to lipodystrophy, but does not exhibit
overt inflammation.
The AZIPtg/+ mouse is a hemizygous transgenic mouse strain
in which a dominant negative protein (A-ZIP) expressed under
the control of the adipose tissue-specific aP2 enhancer/promoter
inhibits expression of members of the C/EBP and Jun families of
transcription factors. AZIPtg/+ mice are born with no WAT and
with severely decreased brown adipose tissue (19). One difference
between Pparg1/1 mice and AZIPtg/+ mice is the presence of
systemic inflammation, suggested in Pparg1/1 mice by the high
levels of Serum Amyloid A (SAA) protein, which is a highly
sensitive marker for inflammation particularly in the acute phase,
and moderate increased levels of IL-1β. In contrast, SAA, IL-1β,
and IL-6 levels were not significantly increased in AZIPtg/+ mice,
indicating that the inflammation in these mice is very low, if not
null (Figure 4A and data not shown).
We thus further analyzed the liver and the spleen of
the lipodystrophic AZIPtg/+ mice. While these animals also
displayed enlarged spleens and a significant increase in total
numbers of hematopoietic mononuclear cells, these increases
were predominantly due to increased numbers of myeloid
and erythroid cells (Supplementary Figure S6). Importantly, the
EMH observed in the absence of PPARγ was recapitulated in
AZIPtg/+ mutants (Figure 4B), with a significant increase in the
numbers of LSK cells in the spleen and the liver, and an increase
of LK cells in the spleen and to a lesser extent in the liver
(Figure 4C).
This observation demonstrated that even though
inflammation likely contributes to the EMH observed in
Pparg1/1 mice, the lipodystrophy per se is responsible for the
EMH.
Distinct Features of the EMH in Pparg1/1
and in AZIPtg/+ Mice
In the BM, inflammation provokes an increased demand on
the granulocyte/macrophage lineage. This lineage is derived
from one of the two cell populations that arise from the
CMPs (defined as CD34+, CD16/32−): the MEPs (CD34−,
CD16/32+) and the GMPs (CD34+, CD16/32+). We thus
further analyzed the relative proportions of MEPs, GMPs, and
CMPs found within the BM, according to these markers (see
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FIGURE 2 | Hematopoietic cell populations in the bone marrow (BM) and peripheral organs of Pparg1/1 mice. (A) Representative FACS plots showing Sca-1 vs.
CD117 staining on lineage-negative BM (left panels), spleen (middle panels), and liver (right panels) cells from littermate control (CTL, upper panels) or Pparg1/1
(lower panels) mice. The red frames on the left and right of each plot indicate the gating and numbers of LK (Lineage-negative, Sca-1−CD117+) and LSK
(Lineage-negative, Sca-1+CD117+) cells, respectively, as a percentage of lineage-negative cells from each organ. (B) Histograms showing the percentage of LSK
(top panel) and LK (bottom panel) cells, with respect to the total cell numbers in the BM, spleen and liver of control (dark bars) and Pparg1/1 (light bars) mice. Mean
± SEM, n = 7–8 mice per genotype. (C) Same as in (B), expressed as absolute numbers of LSK (left panels) and LK cells (right panels). (D) Quantification of LT-HSC
(CD34−CD150+CD48−), MPP1 (CD34+CD150+CD48−), MPP2 (CD34+CD150+CD48+), and MPP3/4 (CD34+CD150−CD48+) subsets in the LSK population of
the BM, spleen, and liver from control (dark bars) and Pparg1/1 (light bars) mice. Mean ± SEM, n = 7–8 mice per genotype. (E) Same as in (D), expressed as a
percentage of the total cell number in the corresponding organ. All significant p-values are indicated above the corresponding bars.
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FIGURE 3 | Extramedullary hematopoiesis is non-cell autonomous. (A) Chimeras using wild-type recipient: Control or Pparg1/1 donor BM (both CD45.2+) was
transferred into wild-type (WT) recipient CD45.1+ mice. Hematopoietic reconstitution was evaluated by FACS analysis 3 months after lethal γ-radiation and i.v. transfer
of T-depleted BM. Left panels: representative FACS plots of Sca-1 vs. CD117 (cKit-r) on lineage-negative donor (CD45.2+) BM (left), spleen (middle) or liver (right) cells
from mice reconstituted with control BM (top row) or Pparg1/1 BM (lower row). The red frames on the left and right of each plot indicate the gating and percentage of
LK (Lineage-negative, Sca-1−CD117+) and LSK (Lineage-negative, Sca-1+CD117+) cells, respectively. Right panels: Relative proportions (in %) of LSK cells (top
panel) and LK cells (bottom panel) over the total cell population of the BM, spleen, and liver. Dark bars represent donor control BM, and light bars represent donor
Pparg1/1 BM, both transplanted into WT host mice. Mean ± SEM, n = 3 mice per genotype. There are no significant p-values. (B) Reverse chimeras: Wild-type (WT)
control donor BM (CD45.1+) was transferred into CTL or Pparg1/1 recipient CD45.2+ mice. Left panels: representative FACS plots of Sca-1 vs. CD117 (cKit-r) on
lineage-negative donor (CD45.1+) BM (left), spleen (middle), or liver (right) cells transferred into either CTL (upper row) or Pparg1/1 (lower row) recipient mice. The red
frames on the left and right of each plot indicate the gating and percentage of LK (Lineage-negative, Sca-1−CD117+) and LSK (Lineage-negative, Sca-1+CD117+)
cells, respectively. Right panels: Relative proportions (in %) of LSK cells (top panel) and LK cells (bottom panel) over the total cell population of the BM, spleen, and
liver. Dark bars represent donor control BM into CTL mice, and light bars represent donor control BM into Pparg1/1 mice. Mean ± SEM, n = 3 mice per genotype.
All significant p-values are indicated above the corresponding bars.
Supplementary Figure S4). In the BM, MEPs were decreased
and GMPs increased, whereas CMPs were unchanged, resulting
in a relatively lower proportion of MEPs and a higher
proportion of granulocyte/macrophage progenitors in the BM
of mice lacking PPARγ compared to wild-type controls
(Figures 5A,B). These results were consistent with the gene
expression profiles of their key regulators, with elevated levels
of both Sfpi/PU1 and Gata2 in the long bones of Pparg1/1
mice compared to control mice, whereas Gata1 remained
unchanged (Figure 5D). Thus, a bias in favor of myeloid over
erythroid development in the BM was observed in the absence
of PPARγ.
Importantly, the observed shift in the ratio of GMPs to MEPs
within the LK subset in Pparg1/1 mice was also recapitulated
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FIGURE 4 | Investigation of extramedullary hematopoiesis in AZIPtg/+ mice.
(A) Serum levels of the inflammatory marker Serum Amyloid A in Pparg1/1
and in AZIPtg/+, evaluated by ELISA. Mean ± SEM for 3 to 8 mice per
genotype. (B) Representative FACS plots showing Sca-1 vs. CD117 staining
on lineage-negative bone marrow (BM; left panels) and spleen (middle panels)
and liver (right panels) cells from AZIPtg/+ (lower row) mice and their wild-type
(WT) littermates (upper row). The red frames on the left and right of each plot
(Continued)
FIGURE 4 | indicate the gating and percentage of LK (Lineage-negative,
Sca-1−CD117+) and LSK (Lineage-negative, Sca-1+CD117+) cells,
respectively, expressed as a percentage of lineage-negative cells from each
organ. (C) Histograms showing total numbers of LSK (left panel) and LK (right
panel) cells in the BM, spleen and liver of WT control (dark bars) and AZIPtg/+
(light hatched bars) mice. Mean ± SEM, n = 3–6 mice per genotype. All
significant p-values are indicated above the corresponding bars.
in the reverse chimeras in the BM (Figures 6A,B), when wild-
type cells were used to reconstitute the BM of irradiated
Pparg1/1 mice. However, in AZIPtg/+ mice, which harbor no
inflammation, increase of the LK cell population was observed in
all progenitor subsets without alteration of theMEP to GMP ratio
(Figure 5C). Consistent with this observation, mRNA expression
levels of the myeloid-promoting transcription factor SFPI1/PU.1
were not increased in the bones of AZIPtg/+ mice (Figure 5D).
Altogether, these data suggest that the increased ratio of GMPs
over MEPs is in part linked to the systemic inflammation,
whereas the EMH is linked to the lipodystrophy context.
Another distinct feature between the phenotypes of Pparg1/1
and AZIPtg/+ mice is that no decrease is observed in the
numbers of B lymphocytes in the BM of AZIPtg/+ mice
(Supplementary Figures S6A,B). Further analyses in Pparg1/1
mice demonstrated more specifically that while the early
immature B cell subsets (PreProB, ProPreB, PreBI and large
and small PreBII) were similar in control and Pparg1/1 mice,
the numbers of later-stage B cells (IgM+ immature and mature
cells) were significantly decreased in the absence of PPARγ (data
not shown). These observations, not seen in AZIPtg/+ mice, are
therefore unlikely to be directly due to the lack of adipocytes in
the BM.
Altered HSC Retention in Lipodystrophic
Mice BM Contributes to EMH in Peripheral
Organs
The next question was therefore which common mechanism
in these two models of lipodystrophy would promote EMH.
One important systemic perturbation observed in these two
models, which is directly due to the lack of adipose tissue,
is a severe type 2 diabetes phenotype with hyperglycemia and
hyperinsulinemia. To evaluate the possible impact of these
metabolic disorders in the induction of EMH, we analyzed
the occurrence of EMH in a well-characterized model of type
2 diabetes, the leptin-deficient ob/ob mice. In contrast to the
Pparg1/1 and AZIPtg/+ mice, no increase in spleen size was
observed in ob/ob mice (data not shown). Moreover, normal
numbers of LSK and LK cells were observed in the spleen of ob/ob
mice (Supplementary Figures S6C,D), thus ruling out metabolic
perturbation as a possible cause of EMH.
As the EMH observed in Pparg1/1 mice was not due to a cell
autonomous defect in hematopoietic cells, and was reproduced
in another model of lipodystrophy, we hypothesized that the
lack of adipocytes or factors produced by adipocytes could be
responsible for this phenomenon. Indeed, one mechanism by
which peripheral organs such as the liver and the spleen harbor
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FIGURE 5 | FACS analyses of progenitor cell subsets in the LK population of the bone marrow (BM), spleen, and liver of Pparg1/1 and AZIPtg/+ mice. (A)
Representative FACS plots of CD34 vs. CD16/32 expression in the LK subset of the BM (left panels), spleen (middle panels) and liver (right panels) of control (CTL,
upper row) and Pparg1/1 (lower row) mice. As there were insufficient liver cells to make a FACS plot for the CTL mice, the gating strategy for the progenitor subsets
is indicated instead. The respective percentages of MEPs (CD34−CD16/32−), CMPs (CD34lowCD16/32−), and GMPs (CD34+CD16/32+) are indicated in each plot.
LK (Lineage-negative, Sca-1−,cKit-r /CD117+); MEP (Megakaryocyte Erythroid Progenitor); CMP (Common Myeloid Progenitor); GMP (Granulocyte Monocyte
Progenitor). (B) Histograms showing the proportion (%) of CMPs, MEPs and GMPs in the BM LK subset of control (dark bars) and Pparg1/1 (light bars) mice. Mean
± SEM, n = 7–8 mice per genotype. (C) Histograms showing the proportion (%) of CMPs, MEPs, and GMPs in the BM LK subset of wild-type (dark bars) and
AZIPtg/+ (light hatched bars) mice. Mean ± SEM, n = 7 mice per genotype. (D) mRNA expression levels of the transcription factors Gata1, Gata2, Sfpi1/PU1
evaluated by qRT-PCR in total cellular extracts from the long bones of control (dark bars) vs. Pparg1/1 mice (light bars) or wild-type (dark bars) and AZIPtg/+ (light
hatched bars) mice. Mean ± SEM, n = 5–7 mice per genotype. All significant p-values are indicated above the corresponding bars.
HSC/progenitor cells is through egression of cells from the BM.
This also occurs under normal homeostatic conditions, since
small numbers of HSC/progenitor cells can be found, albeit at
barely detectable levels, in the peripheral organs of normal mice
(see for example Figures 2A–C).
The lack of adipocytes in the BM of Pparg1/1 and AZIPtg/+
mice may disrupt the local microenvironment. We thus explored
whether the EMH observed in the absence of adipocytes resulted
from an increase in cellular egress from the BM. As the
CXCL12/CXCR4 axis is the main source of retention signals that
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maintain hematopoietic stem and progenitor cells (HSPCs) in
the BM (26), we evaluated the expression levels of this cytokine
(Cxcl12) and its receptor (Cxcr4) in mRNA isolated from the long
bones. These extracts included both stromal and hematopoietic
cell niche components. In the two models we studied, the levels
of Cxcl12 remained unaffected, whereas a significant reduction
of Cxcr4 was observed. Albeit it remains speculative, these results
suggest that the retention of HSPCs in the BMmight be impaired,
contributing to the EMH in Pparg1/1 and in AZIPtg/+ mice.
In contrast, Cxcl12 is decreased in the spleen, whereas Cxcr4
expression is not affected, indicating that these signals do not
contribute to retaining HSCs in the spleen (Figure 7). The
Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor
axis as well as the Parathyroid hormone (PTH) and its receptor
PTHRP, two signals that play a role in this context (27, 28) are not
different between the two genotypes (Figure 7), excluding their
contribution to the phenotype.
Altogether, these results highlight that the occurrence of EMH
in lipodystrophic mouse models results from a lack of adipocytes
and is aggravated when systemic inflammation occurs.
DISCUSSION
In this study, we explored the role of adipocytes in BM
homeostasis and regulation of hematopoiesis and showed that
the total lipodystrophy in Pparg1/1 mice is accompanied by a
severe EMH that impacts upon all hematopoietic lineages. After
a thorough analysis of the cell lineages found in the spleen
and liver, we first demonstrated that the EMH observed in
Pparg1/1 mice is not a direct consequence of the lack of PPARγ
in hematopoietic cells that normally express PPARγ (29, 30).
Indeed, the EMH was reproduced when WT cells were used to
reconstitute lethally irradiated Pparg1/1mice.We then observed
EMH in an independent model of lipodystrophy (AZIPtg/+).
Albeit, we cannot exclude a contribution of inflammation
in Pparg1/1 mice, data from both models indicate that the
most likely causes of EMH are linked to the lipodystrophy
with possible local alterations of the BM microenvironment.
Thus, the combination of the two experimental models of
lipodystrophy used, Pparg1/1 and AZIPtg/+, allowed us to reveal
an important contribution of adiposity in setting the appropriate
BM microenvironment required for normal hematopoiesis.
There are three main known causes of EMH in the clinics
and in experimental settings. The first one is associated
with myelofibrosis disorders, which trigger a compensation in
hematopoietic organs such as the spleen and liver to maintain
functional hematopoiesis (31). Primary myelofibrosis begins as
a myeloproliferative disorder and leads to an altered marrow
with cellular abnormalities. Along this line, EMH has also been
observed in mice carrying hypomorphic Pparg alleles and was
shown to result from structural changes in the bones and thus
reduced numbers of BM cells (32). In contrast, we found here
that the BM in Pparg1/1 and AZIPtg/+ mice exhibited close
to normal cell numbers, with neither myeloproliferation nor
dramatic changes in theHSC population, excludingmyelofibrosis
as the cause of EMH. The second main cause of EMH
is hypoxia, in which the increased need of red blood cell
production is the trigger. The stress response to hypoxia in the
context of hemoglobinopathy (33) stimulates erythropoiesis and
increases hematocrit. Again, neither increases in erythropoiesis
nor increased hematocrit were observed in the absence of PPARγ
or in AZIPtg/+ mice, making this hypothesis also unlikely.
The third main cause of EMH is the presence of severe
systemic inflammation, particularly in rodents, where it is
associated with a marked increase in granulopoiesis (17). Local
skin inflammation is indeed observed in Pparg1/1 mice and
was associated with PPARγ-dependent scarring alopecia (18).
However, this feature is specific to Pparg1/1 mice and not
found in AZIPtg/+ mice. In addition, the blood levels of the
inflammatory markers are significantly increased in Pparg1/1
mice but not in AZIPtg/+ mice. Thus, although we cannot rule
out a contribution of inflammation, particularly in the case of
the Pparg1/1 mice, it does not explain the presence of EMH in
AZIPtg/+ mice. These distinct features in terms of inflammation
also provide an explanation for the biased development of CMPs
toward the myeloid lineage at the expense of the erythroid
and megakaryocyte lineages seen only in Pparg1/1 and not in
AZIPtg/+ mice. The inflammation seen in the former and not in
the latter likely contributes to this shift in CMP commitment. The
resulting relative decrease in the number of erythroblasts in the
BM of Pparg1/1 mice might thus be compensated for by active
EMH.
Finally, although the three mouse models described in this
study (Pparg1/1, AZIPtg/+, and ob/ob) are all affected by type
2 diabetes, the fact that ob/obmice did not exhibit EMH excludes
this systemic metabolic disorder as a common causative factor.
Thus in this context, the most likely hypothesis is that adipocytes
function to contribute to hematopoietic homeostasis in the BM.
The BM transfer experiment that we performed clearly
indicates that the bone cavity micro-environment was involved
in the EMH observed in our experimental models. The BM stem
cell niche concept was first defined as a local microenvironment
that maintains and regulates the function of stem and progenitor
cells (1), and many cell types have been shown to be involved in
these processes [reviewed in (2–4)]. BM adipocytes may or may
not be considered as part of the niche per se, but they are present
in large numbers and could contribute to the microenvironment
in several ways. First, they play a role in bone homeostasis,
which may indirectly affect the BM stem cell niche. This is
due to the fact that adipocytes and osteoblasts are linked via
their common mesenchymal progenitors, resulting in a balance
between adipogenesis and osteoblastogenesis. PPARγ is central
in this balance since this nuclear factor is a crucial regulator of
MSC orientation toward adipocytes, as it’s ex vivo or in vitro
activation using synthetic agonists results in an adipogenic MSC
phenotype, whereas it’s pharmacological blockade or genetic
deletion result in the opposite phenotype i.e., an osteoblastic
phenotype (34, 35). Moreover, leptin and adiponectin, which are
secreted by adipocytes, also exert a local and systemic role in bone
homeostasis [reviewed in (36)]. Second, a direct function for
adipocytes in supporting the proliferation of hematopoietic cells
has been proposed, albeit the nature of this support function is
not well described. It could combine energy sources and specific
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FIGURE 6 | FACS analyses of progenitor cell subsets in the LK population in chimeras and AZIPtg/+ mice. (A) Chimeras using wild-type recipients and control or
Pparg1/1 donor BM. Hematopoietic reconstitution was evaluated by FACS analysis 3 months after the transfer (see also Figure 3A). The histograms show the
proportion (%) of CMPs (CD34lowCD16/32−), MEPs (CD34−CD16/32−), and GMPs (CD34+CD16/32+) in the LK cell subset, in the BM, the spleen and the liver of
WT mice reconstituted with control (dark bars) or Pparg1/1 (light bars) BM. Mean ± SEM, n = 3 mice per genotype. No significant p-value. (B) Reverse chimeras
using wild-type (WT) control donor BM transferred into Pparg1/1 or their littermate control (CTL) recipient. The histograms show the proportion (%) of CMPs, MEPs
and GMPs in the LK cell subset in the BM, the spleen and the liver of control (dark bars) or Pparg1/1 (light bars) mice reconstituted with wild-type donor BM. Mean ±
SEM, n = 3 mice per genotype. All significant p-values are indicated above the corresponding bars.
adipokines, which have been proposed to mediate various aspects
of HSC maintenance, quiescence and proliferation in vitro (9,
37, 38). In contrast, two reports have shown an anti-correlation
between the number of adipocytes present in the bone cavity
and the rapidity of recovery after BM irradiation (13, 39). One
possible way to reconcile these conflicting observations is that the
support provided by adipocytesmay differ between in vitro and in
vivo conditions as proposed by Spindler et al. (40). In agreement
with our results, it is tempting to speculate on a specific role for
BM adipocytes in this phenotype. However, our experiments do
not exclude the possibility of a systemic cue directly related to the
generalized lipoatrophy.
A possible consequence of an altered BM microenvironment
is a modification of the balance between active retention and
mobilization of HSCs. We showed that in the absence of PPARγ,
all hematopoietic lineages are increased. Thus, the most likely
explanation for the observed EMH is reduced BM colonization
at birth or an increase in egress of HSCs and early progenitors
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FIGURE 7 | Gene expression of key factors of cell egress from the BM in Pparg1/1 and AZIPtg/+ mice. (A,B) Cxcl12 and Cxcr4 mRNA expression in the long bones
of Pparg1/1 (A) and AZIPtg/+ (B) mice and their controls, CTL and WT, respectively, as indicated. Mean ± SEM for 3 to 6 mice per genotype. (C,D) Cxcl12 and
Cxcr4 mRNA expression in the spleen (C; Mean ± SEM for 5 mice per genotype) and the liver (D; Mean ± SEM for 6 to 7 mice per genotype) of Pparg1/1 mice and
their control. (E) Expression levels of Sphingosine Sphingosine kinase/sphingosine 1-phosphate receptors genes, S1pr1, S1pr2, S1pr3, in the long bone of Pparg1/1
mice and their control. (F) Parathyroid hormone (PTH) serum levels and gene expression of its receptor PTHR1 in long bones of Pparg1/1 mice and their control
Mean ± SEM for 3 to 4 mice per genotype. All significant p-values are indicated above the corresponding bars.
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from the BM. This is consistent with the fact that HSCs within
the BM are very mobile cells, and that a small number of HSCs
are constantly released into the circulation (41). Nevertheless, the
best characterized mechanism of HSC and progenitor cell egress
from the BM is the one provoked by pharmacological doses of
G-CSF administered to patients for stem cell mobilization prior
to autologous transplantation. This involves down-regulation of
CXCL12, which is expressed by perivascular MSCs and CAR
cells, as well as by osteoblast lineage cells. This decreased
expression prevents interaction of CXCL12 with its receptor
CXCR4 expressed by HSCs and progenitors, and the retention
and survival of HSCs and progenitor cells in the BM (42, 43).
In the models presented herein, Cxcl12 expression levels in
the BM were not altered, but gene expression of its receptor
CXCR4 was significantly impaired. Pharmacological antagonists
of CXCR4 are among the main recent innovations improving
HSC mobilization in patients (44). Altogether, our observations
are consistent with an alteration of the BM microenvironment
due to the total lack of adipocytes, with loss of retention and/or
increased egress of HSCs and progenitor cells from the BM
to the peripheral organs, albeit this mechanistic hypothesis
remains speculative. Nevertheless, we cannot completely exclude
the contribution of an increased pool of splenic HSCs during
development in both models of lipodystrophic mice. This could
be due to reduced BM colonization at birth, when stem cell niches
are being formed, or to an increased retention in spleen and
liver, which are the primary sites of hematopoiesis before birth,
although the decrease in CXCL12 expression in the spleen, does
not favor this hypothesis.
The main limitation of the present study originates from the
fact that mice, like most rodents, are more prone to develop
EMH than humans. Nonetheless, our results strongly support
the fact that lack or scarcity of adipocytes is deleterious for
BM hematopoiesis. A deeper analysis of the adipocytes in
the BM stem cell niche itself, more particularly with respect
to their paracrine activity and cell-cell contacts may help to
better define the role of adipocytes in cell retention/egress from
the BM and highlight the importance of some key factors of
interest for clinical situations of BM transfer. Alternately, and
not exclusively, the search for a systemic cue linked to the
generalized lipodystrophymight provide new avenues of research
in hematopoiesis.
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